🍪 Our Cookies

This website uses cookies, pixel tags, and similar technologies (“Cookies”) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking “Accept All” you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data. You can manage your consent preferences by clicking Manage Preferences. You may withdraw a consent at any time by using the link “Cookie Preferences” in the footer of our website.

Our Privacy Notice is accessible here. To learn more about the use of Cookies on our website, please view our Cookie Notice.

Jefferies leads financing for KKR’s bid for Simon & Schuster

Share

News and Analysis

Jefferies leads financing for KKR’s bid for Simon & Schuster

Will Caiger-Smith's avatar
Bill Weisbrod's avatar
  1. Will Caiger-Smith
  2. +Bill Weisbrod
1 min read

Jefferies is leading a group of banks and other underwriters to provide debt commitments backing KKR’s bid to acquire Simon & Schuster, according to 9fin sources.

The publishing company’s current owner, Paramount Global, has been searching for a buyer for several months. Bidders have included News Corp and HarperCollins, but news broke last week that the company was set to announce a deal with KKR.

The Jefferies-led debt commitment provides for term loans that will lever the company in the region of 4x-5x, one of the sources said. The underwriter group features multiple Wall Street firms, including KKR’s own capital markets arm.

As is customary for a bank-led financing, the debt is expected to be syndicated to institutional investors. The deal would represent another win for banks, who are competing with direct lenders in order to win lucrative LBO financing mandates.

In just the past two weeks, several large buyout financings have been snapped up by private credit firms, including deals for NextechNew Relic and Worldwide Clinical Trials.

KKR declined to comment. Jefferies and Paramount Global did not immediately respond to messages seeking comment.

What are you waiting for?

Try it out
  • We're trusted by the top 10 Investment Banks